Sialoproteinaemia: lack of correlation with inhibition of in vitro lymphoblastosis induced by phytohaemagglutinin or alloantigen.
Elevation of serum-bound sialic acid concentration in different disease states fails to correlate significantly with suppressive serum actions in mixed allogeneic lymphocyte cultures or phyto-haemagglutinin cultures. Heat-decomplemented serum from patients with abnormal levels of bound sialic acid was added to parallel cultures containing similar blood lymphocyte populations derived from normal humans. Wide fluctuations of the rate of incorporation of tritiated thymidine into nucleoprotein indicated presence of suppressive elements other than sialoprotein in the added serum components. Serum with rising sialyl concentration derived from patients with cancer showed slight tendency to augment mixed lymphocyte and phytohaemagglutinin responses. The findings suggest that the previously documented nonspecific suppressive action of serum sialoprotein on human host lymphoblastic response to neuraminidase-treated cancer cells represents a mechanism unique to that culture system rather than a manifestation of a general immunoregulatory function of serum sialoprotein.
D001796:Blood Protein Disorders / Q000276:immunology*; D006023:Glycoproteins / Q000097:blood; D006801:Humans; D007519:Isoantigens; D007676:Kidney Failure, Chronic / Q000276:immunology; D037102:Lectins / Q000494:pharmacology; D008107:Liver Diseases / Q000276:immunology; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D009369:Neoplasms / Q000276:immunology; D011485:Protein Binding; D012794:Sialic Acids / Q000097:blood*
D006023:Glycoproteins; D007519:Isoantigens; D037102:Lectins; D012794:Sialic Acids